Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications
BACKGROUND: Knowledge on prevalence, comorbidities and consequences of chronic kidney disease (CKD) is mandatory to
26 March 2025
BACKGROUND: Knowledge on prevalence, comorbidities and consequences of chronic kidney disease (CKD) is mandatory to
BACKGROUND: Hormonal receptor (HR) positive breast tumors are common. Adjuvant hormonal therapy (AHT) with tamoxifen
OBJECTIVE: Dutch diabetes guidelines have been updated to incorporate specific therapies with cardiovascular and kidney
nformation on healthcare utilization and costs of general practitioner (GP)-guided care in patients with musculoskeletal
RMMs’ impact on antibiotic prescriptions in primary care during 2014-2023. METHODS: We assessed antibiotic prescriptions
OBJECTIVES: Iron deficiency anemia is a significant global health concern, diagnosed by measuring hemoglobin concentrations
INTRODUCTION: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and
PURPOSE: In clinical practice, a discrepancy may exist between the prescribed amount of a drug
BACKGROUND: Pharmacological treatment is a cornerstone of chronic obstructive pulmonary disease (COPD) management, with general
AIMS/HYPOTHESIS: Only a few studies reported the incidence of type 2 diabetes (T2D). Understanding recent